This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chorro, F. J. Articles by López-Merino, V. Search for Related Content PubMed PubMed Citation Articles by Chorro, F. J. Articles by López-Merino, V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB VERAPAMIL HYDROCHLORIDE Related Collections Arrythmias-basic studies Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2000;101:1606.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Alteration of Ventricular Fibrillation by Flecainide, Verapamil, and Sotalol

An Experimental Study

Francisco J. Chorro, MD; Joaquín Cánoves, MD; Juan Guerrero, PhD; Luis Mainar, MD; Juan Sanchis, MD; Luis Such, MD; Vicente López-Merino, MD

From the Service of Cardiology, Valencia University Clinic Hospital (F.J.C., J.C., L.M., J.S., V.L.-M.), and the Departments of Electronics (J.G.) and Physiology (L.S.), Valencia University, Valencia, Spain.

Correspondence to Francisco J. Chorro, Servicio de Cardiología, Hospital Clínico Universitario, Avda Blasco Ibañez-17, 46010-Valencia, Spain.

Background—The purpose of this study was to determine whether the myocardial electrophysiological properties are useful for predicting changes in the ventricular fibrillatory pattern.

Methods and Results—Thirty-two Langendorff-perfused rabbit hearts were used to record ventricular fibrillatory activity with an epicardial multiple electrode. Under control conditions and after flecainide, verapamil, or d,l-sotalol, the dominant frequency (FrD), type of activation maps, conduction velocity, functional refractory period, and wavelength (WL) of excitation were determined during ventricular fibrillation (VF). Flecainide (1.9±0.3 versus 2.4±0.6 cm, P<0.05) and sotalol (2.1±0.3 versus 2.5±0.5 cm, P<0.05) prolonged WL and diminished FrD during VF, whereas verapamil (2.0±0.2 versus 1.7±0.2 cm, P<0.001) shortened WL and increased FrD. Simple linear regression revealed an inverse relation between FrD and the functional refractory period (r=0.66, P<0.0001), a direct relation with respect to conduction velocity (r=0.33, P<0.01), and an inverse relation with respect to WL estimated during VF (r=0.49, P<0.0001). By stepwise multiple regression, the functional refractory periods were the only predictors of FrD. Flecainide and sotalol increased the circuit size of the reentrant activations, whereas verapamil decreased it. The 3 drugs significantly reduced the percentages of more complex activation maps during VF.

Conclusions—The activation frequency is inversely related to WL during VF, although a closer relation is observed with the functional refractory period. Despite the diverging effects of verapamil versus flecainide and sotalol on the activation frequency, WL, and size of the reentrant circuits, all 3 drugs reduce activation pattern complexity during VF.

Key Words: ventricular fibrillation • mapping • antiarrhythmic agents • electrophysiology

This article has been cited by other articles:

				I. Panfilov, N. A. Lever, B. H. Smaill, and P. D. Larsen Ventricular fibrillation frequency from implanted cardioverter defibrillator devices Europace, June 23, 2009; (2009) eup159v1. [Abstract] [Full Text] [PDF]

				O. Aydin, R. Becker, P. Kraft, F. Voss, M. Koch, K. Kelemen, H. A. Katus, and A. Bauer Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts Europace, November 1, 2007; 9(11): 1094 - 1098. [Abstract] [Full Text] [PDF]

				M. Warren, J. F. Huizar, A. G. Shvedko, and A. V. Zaitsev Spatiotemporal Relationship Between Intracellular Ca2+ Dynamics and Wave Fragmentation During Ventricular Fibrillation in Isolated Blood-Perfused Pig Hearts Circ. Res., October 26, 2007; 101(9): e90 - e101. [Abstract] [Full Text] [PDF]

				A. V. Zaitsev, P. K. Guha, F. Sarmast, A. Kolli, O. Berenfeld, A. M. Pertsov, J. R. de Groot, R. Coronel, and J. Jalife Wavebreak Formation During Ventricular Fibrillation in the Isolated, Regionally Ischemic Pig Heart Circ. Res., March 21, 2003; 92(5): 546 - 553. [Abstract] [Full Text] [PDF]

				F. J. Chorro, J. Guerrero, A. Ferrero, A. Tormos, L. Mainar, J. Millet, J. Canoves, J. C. Porres, J. Sanchis, V. Lopez-Merino, et al. Effects of acute reduction of temperature on ventricular fibrillation activation patterns Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2331 - H2340. [Abstract] [Full Text] [PDF]

				J. Huang, J. L. Skinner, J. M. Rogers, W. M. Smith, W. L. Holman, and R. E. Ideker The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs J. Am. Coll. Cardiol., July 17, 2002; 40(2): 375 - 383. [Abstract] [Full Text] [PDF]

				M.-H. Lee, S.-F. Lin, T. Ohara, C. Omichi, Y. Okuyama, E. Chudin, A. Garfinkel, J. N. Weiss, H. S. Karagueuzian, and P.-S. Chen Effects of diacetyl monoxime and cytochalasin D on ventricular fibrillation in swine right ventricles Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2689 - H2696. [Abstract] [Full Text] [PDF]

				A. Benardeau, S. Fareh, and S. Nattel Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs Cardiovasc Res, April 1, 2001; 50(1): 85 - 96. [Abstract] [Full Text] [PDF]

				M. Swissa, Z. Qu, T. Ohara, M.-H. Lee, S.-F. Lin, A. Garfinkel, H. S. Karagueuzian, J. N. Weiss, and P.-S. Chen Action potential duration restitution and ventricular fibrillation due to rapid focal excitation Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1915 - H1923. [Abstract] [Full Text] [PDF]